Interest in reducing methamphetamine and opioid use among syringe services program participants in Washington State

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Among PWID whose main drug was an opioid, female gender was associated with more than twice the odds of interest in reducing or stopping opioid use (AOR 2.19, 95% CI 1.11-4.29, p = .023) compared to m

Effect: improvement; AOR 2.19; CI: 95% CI: 1.11-4.29

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among opioid users interested in reducing use, 71% reported methadone, buprenorphine, or naltrexone as the type of help they would want if it were easy to get.

Effect: improvement; 71%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%